TWI250027B - Improved growth stimulant compositions - Google Patents

Improved growth stimulant compositions Download PDF

Info

Publication number
TWI250027B
TWI250027B TW088119044A TW88119044A TWI250027B TW I250027 B TWI250027 B TW I250027B TW 088119044 A TW088119044 A TW 088119044A TW 88119044 A TW88119044 A TW 88119044A TW I250027 B TWI250027 B TW I250027B
Authority
TW
Taiwan
Prior art keywords
composition
weight
controlled release
release formulation
formulation
Prior art date
Application number
TW088119044A
Other languages
English (en)
Chinese (zh)
Inventor
Chung Shih
Thomas J Kennedy
Peter James Knight
Daniel S Robins
Zezhi Jesse Shao
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of TWI250027B publication Critical patent/TWI250027B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A61K9/204—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Fodder In General (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Feed For Specific Animals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
TW088119044A 1998-11-04 1999-11-02 Improved growth stimulant compositions TWI250027B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US18594498A 1998-11-04 1998-11-04

Publications (1)

Publication Number Publication Date
TWI250027B true TWI250027B (en) 2006-03-01

Family

ID=22683037

Family Applications (1)

Application Number Title Priority Date Filing Date
TW088119044A TWI250027B (en) 1998-11-04 1999-11-02 Improved growth stimulant compositions

Country Status (11)

Country Link
AR (1) AR025133A1 (es)
AU (1) AU777393B2 (es)
BR (2) BR9914996A (es)
CA (1) CA2348841C (es)
CO (1) CO5140100A1 (es)
CR (1) CR6351A (es)
MY (1) MY134868A (es)
PE (1) PE20001092A1 (es)
TW (1) TWI250027B (es)
WO (1) WO2000025743A2 (es)
ZA (1) ZA200103494B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020131988A1 (en) * 1999-12-16 2002-09-19 Foster Todd P. Pharmaceutical implant containing immediate-release and sustained-release components and method of administration
US6953586B1 (en) * 2000-06-08 2005-10-11 Ivy Animal Health, Inc. Growth promoting pharmaceutical implant
EP4000688A1 (en) 2020-11-19 2022-05-25 F.I.S.- Fabbrica Italiana Sintetici S.p.A. Process for the preparation of trenbolone acetate having a definite particle size distribution
EP4001288A1 (en) 2020-11-19 2022-05-25 F.I.S.- Fabbrica Italiana Sintetici S.p.A. Process for the preparation of trenbolone acetate having a definite particle size distribution and a irregular hexagon plates crystal habit
EP4001289B1 (en) 2020-11-19 2023-05-03 F.I.S.- Fabbrica Italiana Sintetici S.p.A. Improved process for the preparation of trenbolone and/or trenbolone acetate

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2573307B1 (fr) * 1984-11-22 1988-06-10 Virbac Ctre Rech Biolog Implants anabolisants a liberation prolongee
US4670249A (en) * 1985-04-12 1987-06-02 International Minerals & Chemical Corp. Growth-promoting compositions
US5219572A (en) * 1989-03-17 1993-06-15 Pitman-Moore, Inc. Controlled release delivery device for macromolecular proteins
US5747060A (en) * 1996-03-26 1998-05-05 Euro-Celtique, S.A. Prolonged local anesthesia with colchicine
US5874098A (en) * 1997-05-28 1999-02-23 Ivy Laboratories, Inc. Pellet implant system

Also Published As

Publication number Publication date
CA2348841A1 (en) 2000-05-11
BRPI9914996B8 (pt) 2021-07-06
AR025133A1 (es) 2002-11-13
BR9914996A (pt) 2001-07-10
WO2000025743A3 (en) 2000-08-24
AU777393B2 (en) 2004-10-14
CA2348841C (en) 2007-04-17
WO2000025743A2 (en) 2000-05-11
BRPI9914996A (pt) 2001-07-10
PE20001092A1 (es) 2000-10-31
ZA200103494B (en) 2002-07-30
BRPI9914996B1 (pt) 2011-11-01
CO5140100A1 (es) 2002-03-22
MY134868A (en) 2007-12-31
AU3096700A (en) 2000-05-22
CR6351A (es) 2003-11-20

Similar Documents

Publication Publication Date Title
US7999005B2 (en) Growth stimulant compositions
AU783538B2 (en) Pharmaceutical implant containing immediate-release and sustained-release components and method of administration
CN1205921C (zh) 含有氢化蓖麻油的长效注射制剂
US4568536A (en) Controlled release of pharmacologically active agents from an absorbable biologically compatible putty-like composition
JP2001509146A (ja) ゲル組成物および方法
HU226711B1 (en) Liquid polymeric compositions for controlled release of bioactive substances
JP2005505557A (ja) 持続放出医薬組成物の調製
US20070031500A1 (en) Long-acting solid formulation comprising triptorelin acetate
AU710539B2 (en) Pharmaceutical compositions for the sustained release of insoluble active principles
TWI250027B (en) Improved growth stimulant compositions
JP2005517653A (ja) Ｘ線不透過性徐放性医薬器具
US20070166377A1 (en) Sustained-release drug formulations
KR20020068377A (ko) 멜렌게스트롤 아세테이트 및 트렌볼론 아세테이트를함유한 이식제 조성물
JP2001517622A (ja) 殺寄生生物製剤
CN1206001C (zh) 生物可降解载体和生物可降解传输系统
JP2005538052A (ja) 注射製剤
JPH01149732A (ja) ソマトトロピン製剤
WO2000047232A1 (fr) Implant a liberation prolongee, son procede de preparation et traitement du cancer
JPS63203610A (ja) 複数成分からなるインプラント用の持効性医薬製剤
JP2002506797A (ja) 生体活性物質の制御放出用液体ポリマー組成物
AU753759B2 (en) Improvements in and relating to implants for delivering B12 compounds

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees